The administration of probiotics and synbiotics in immune compromised adults: is it safe?
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
This study aimed to systematically evaluate safety of probiotics and synbiotics in immune compromised adults (≥18 years). Safety was analysed using the Common Terminology Clinical Adverse Events (CTCAE version 4.0) classification, thereby providing an update on previous reports using the most recent available clinical data (2008-2013). Safety aspects are represented and related to number of participants per probiotic strain/culture, study duration, dosage, clinical condition and selected afflictions. Analysis of 57 clinical studies indicates that probiotic and/or synbiotic administration in immune compromised adults is safe with regard to the current evaluated probiotic strains, dosages and duration. Individuals were considered immune compromised if HIV-infected, critically ill, underwent surgery or had an organ- or an autoimmune disease. There were no major safety concerns in the study, as none of the serious adverse events (AE)s were related, or suspected to be related, to the probiotic or synbiotic product and the study products were well tolerated. Overall, AEs occurred less frequent in immune compromised subjects receiving probiotics and/or synbiotics compared to the control group. In addition, the results demonstrated a flaw in precise reporting and classification of AE in most studies. Furthermore, generalisability of conclusions are greatly limited by the inconsistent, imprecise and potentially incomplete reporting as well as the variation in probiotic strains, dosages, administration regimes, study populations and reported outcomes. We argue that standardised reporting on adverse events (CTCAE) in ‘food’ studies should be obligatory, thereby improving reliability of data and re-enforcing the safety profile of probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954 · cited 1×
“Subjects with an organ disease, such as liver cirrhosis, own increased susceptibility to infections by opportunistic organisms due to defective microbial clearance (Fernández et al., 2002; Mookerjee et al., 2007).”
BackgroundNewberry, S. J. (2012) · JAMA · doi:10.1001/jama.2012.3507 · Cited by 870 · cited 2×
“Nevertheless, probiotics demonstrated to be promising in several areas, for instance in reducing the incidence of infection, antibiotic associated diarrhoea and intensive care unit stay (Barraud et al., 2013; Hempel et al., 2012; Morrow et al., 2012).”
BackgroundAn update on the use and investigation of probiotics in health and disease
Sanders, M. E., Guarner, F., Guerrant, R., Holt, P. R., Quigley, E. M., Sartor, R. B., Sherman, P. M., & Mayer, E. A. (2013) · Gut · doi:10.1136/gutjnl-2012-302504 · Cited by 503 · cited 2×
“A high number of randomised trials have been conducted to prove probiotic efficacy with contradicting results (Sanders et al., 2013).”
BackgroundResultSelf-citationTursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489 · cited 1×
“…2009 Matthes et al., 2010 Tanaka et al., 2012 Gao et al., 2010 Mittal et al., 2011 Tandon et al., 2009 Gianotti et al., 2010 Morrow et al., 2010 Tursi et al., 2010 González-Hernández et al., 2012 Peguet-Navarro et al., 2008 Usami et al., 2011 Hemsworth et al., 2012 Peral et al., 2009 Zhang et…”
BackgroundSalminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426
World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics October 2011
Guarner, F., Khan, A. G., Garisch, J., Eliakim, R., Gangl, A., Thomson, A., Krabshuis, J., Lemair, T., Kaufmann, P., de Paula, J. A., et al. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182549092 · Cited by 418 · cited 1×
“A combination of probiotics and prebiotics is referred to as a synbiotic (Guarner et al., 2012).”
BackgroundSelf-citationGao, X. W., Mubasher, M., Fang, C. Y., Reifer, C., & Miller, L. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.11 · Cited by 318 · cited 1×
“…and Hewett, 2012 Frohmader et al., 2010 Mangell et al., 2012 Tan et al., 2011 Fujimori et al., 2009 Matthes et al., 2010 Tanaka et al., 2012 Gao et al., 2010 Mittal et al., 2011 Tandon et al., 2009 Gianotti et al., 2010 Morrow et al., 2010 Tursi et al., 2010 González-Hernández et al., 2012…”
BackgroundLESERMAN, J., PETITTO, J. M., GU, H., GAYNES, B. N., BARROSO, J., GOLDEN, R. N., PERKINS, D. O., FOLDS, J. D., & EVANS, D. L. (2002) · Psychological Medicine · doi:10.1017/s0033291702005949 · Cited by 311 · cited 2×
“None of the allocated participants had a CD4 + T cell count below 200 cells/mm 3 , a marker for clinical progression to AIDS and heavily increased risk of developing infections (Leserman et al., 2002 ).”
Background
Cited by
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
Flach, J., van der Waal, M. B., van den Nieuwboer, M., Claassen, E., & Larsen, O. F. A. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1334624 · Cited by 131
“Probiotic administration is generally recognized as safe (Borriello et al., 2003; Van den Nieuwboer et al., 2014a; Van den Nieuwboer et al., 2014b; Van den Nieuwboer et al., 2015; FDA, 2016) and a reduced risk for antibiotic-associated diarrhea (AAD), necrotizing enterocolitis (NEC) and…”
BackgroundProbiotics: If It Does Not Help It Does Not Do Any Harm. Really?
Lerner, A., Shoenfeld, Y., & Matthias, T. (2019) · Microorganisms · doi:10.3390/microorganisms7040104 · Cited by 117
“summarized it clearly: “generalizability of conclusions are greatly limited by the inconsistent, imprecise, and potentially incomplete reporting as well as the variation in probiotic strains, dosages, administration regimes, study populations, and reported outcomes” [148].”
BackgroundInfluentialSafety of probiotics and synbiotics in children under 18 years of age
van den Nieuwboer, M., Brummer, R. J., Guarner, F., Morelli, L., Cabana, M., & Claassen, E. (2015) · Beneficial Microbes · doi:10.3920/bm2014.0157 · Cited by 83
“This update is in line with previous analyses, indicating that probiotics are safe, even in infants and immune compromised adults (Hempel et al., 2011; Van den Nieuwboer et al., 2014, 2015).”
ResultSelf-citationGhavami, A., Khorvash, F., Heidari, Z., Khalesi, S., & Askari, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105668 · Cited by 62
Tapiovaara, L., Lehtoranta, L., Poussa, T., Mäkivuokko, H., Korpela, R., & Pitkäranta, A. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0096 · Cited by 26
Safety of Probiotics in Health and Disease
Daliri, E. B.-M., Lee, B. H., & Oh, D. H. (2019) · The Role of Functional Food Security in Global Health · doi:10.1016/b978-0-12-813148-0.00034-7 · Cited by 21
Finamore, A., Peluso, I., & Serafini, M. (2016) · Probiotics, Prebiotics, and Synbiotics · doi:10.1016/b978-0-12-802189-7.00041-1 · Cited by 4
Metadata
- Authors
- Van den Nieuwboer, M., Brummer, R. J., Guarner, F., Morelli, L., Cabana, M., & Claassen, E.
- Venue
- Beneficial Microbes
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-01-01
- Volume
- 6
- Issue
- 1
- Pages
- 3-18
- ISSN
- 1876-2883 (ISSN-L)
- 1876-2891
- OpenAlex
- W2130986448
- Cited by
- 98
- References
- 16
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.